Health
Biological E. Limited gets CDSCO Nod to Start Phase III Clinical Trial of its COVID-19 Vaccine Candidate – United News of India
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed…
Hyderabad, Apr 24 (UNI) Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company on Saturday announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC).BE started the Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate in the second week of November…
-
Noosa News23 hours agoDeputy Premier defends far-right rally’s right to protest, but urges calm
-
General24 hours agoThreat warning lingers over anti-migrant rallies
-
General23 hours agoScottish brothers finish mammoth row across Pacific Ocean after 139 days
-
Business13 hours agoThink Nvidia stock is expensive? This chart might change your mind.